Key Points Kevin is a shareholder of Buchanan Ingersoll & Rooney in Washington, DC, where he focuses on corporate finance and emerging technology companies. The Council is a dedicated group who provide advice and assist with raising funds and building awareness. We are pleased to welcome Kevin Passarello to the Foundation’s Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness. Kevin is a shareholder of Buchanan Ingersoll & Rooney in Washington, DC, where he focuses on corporate finance and emerging technology companies. He leads the Firm’s university technology transfer initiatives and co-chairs its Advanced Technologies Group. Kevin also recently completed a five-year appointment as the Director of Translational Programs and Development at the Biocomplexity Institute and Initiative at the University of Virginia. After practicing law for 12 years, Kevin went into business in 1999 and has become a serial entrepreneur. He co-founded venture-backed technology companies in the areas of enterprise software, mobile hardware, and artificial intelligence in health care. He served in various capacities in these companies, including as CEO, COO, and general counsel. Kevin also co-founded a private equity management and advisory firm. He has been an entrepreneur-in-residence at the University of Virginia, Virginia Tech, and Virginia Commonwealth University. He also served for three years as an Innovation Fellow in Biocomplexity at Virginia Tech. “Kevin brings a wealth of experience in commercializing early-stage technologies, as well as a personal network of thought leaders and investors who can help advance focused ultrasound,” said Foundation Chairman Neal F. Kassell, MD. “Kevin will also be joining the advisory committee of the Foundation’s FUS Partners program, which is responsible for facilitating the commercialization of the technology.” “I am honored to join such excellent staff and preeminent directors and advisors in advancing the Foundation’s vision of noninvasive and effective care for otherwise intractable diseases through focused ultrasound therapies,” Kevin added. Kevin received his BA, ranking as valedictorian, from St. Vincent College in 1983, where he studied philosophy and classical languages. He earned his JD from Georgetown University Law Center in 1986, and then served as law clerk to the (Late) Hon. Carol Los Mansmann of the US Court of Appeals for the Third Circuit.
Key Points As a teenager, Anya developed debilitating obsessive-compulsive disorder symptoms that eventually led to suicidal ideation and treatment in an in-patient facility. Now, thanks to focused ultrasound, her symptoms are under control and she is looking forward to exciting new milestones. When Anya was in her late teens, she began noticing some new psychological symptoms. “Initially, it was mostly rituals or behavioral quirks, and most people weren’t even aware I was struggling with them. I remember thinking that I needed to open my computer or unlock my phone at a specific time that was a multiple of five. I would also follow the traffic signals when I was walking, so I would switch sides of the street along with the signals. It honestly felt like a bit of a game at first.” But when she was 21, Anya and her boyfriend of three years parted ways, leading to a sudden onset of obsessive-compulsive disorder (OCD) symptoms. Soon after that, she received her official diagnosis. “My symptoms really escalated. The compulsive behaviors stopped abruptly, but instead I began to have intrusive thoughts and obsessions. I felt like I had a non-stop radio in my head that just wouldn’t quiet. I was getting a lot of earworms, or snippets of lyrics and music stuck in my head repeating over and over again all day long, which was really excruciating. I started to realize that music was everywhere. I couldn’t go into stores, and even photos could trigger the earworms. I never had a clear head space. I was constantly having really invasive, intrusive thoughts.” Following her diagnosis, Anya tried many different medications and therapy to help ease her OCD symptoms. Unfortunately, none of these interventions seemed to help. Her symptoms made it challenging to maintain relationships, and she was dependent on her parents for daily tasks. She became depressed and even experienced suicidal ideation. She was eventually admitted to a hospital for in-patient psychiatric care. “I first got a glimmer of hope when I learned from a fellow patient that medication and therapy were no longer the only treatment options; neuroscientists were experimenting with neuromodulation. He told me about transcranial magnetic stimulation (TMS), and I travelled to Seattle and Tel Aviv to try that treatment. Unfortunately, it did not help with my symptoms, but it made me open to the idea of an intervention that directly targeted the brain.” Nearly two years after her diagnosis, Anya learned about and was approved for focused ultrasound treatment at Sunnybrook Health Sciences Centre in Toronto. Focused ultrasound is a noninvasive therapy that uses intersecting beams of ultrasound guided by real-time imaging to treat tissue deep in the body, or in Anya’s case, the brain. The therapy is cleared to treat 15 diseases in North America, including essential tremor, Parkinson’s disease symptoms, prostate cancer, liver tumors, and uterine fibroids. However, it is still experimental for OCD, so Anya took part in a clinical trial. On the morning of her treatment in early 2019, Anya felt hopeful. “I felt like I really had nothing to lose. At that point, I had been severely ill for more than two years, and it was a living hell. I was so desperate to get better that I wasn’t scared of the procedure itself. I was only scared of the possibility that it might not help.” Before the treatment, nurses shaved Anya’s head because tiny air bubbles that can get trapped in hair would interfere with the ultrasound waves. She then went into an MRI machine that was outfitted with a helmet-like focused ultrasound device. Anya was awake during the treatment, and she was given a button that would allow her to stop the procedure at any time. “I just remember thinking that this was my last hope, and I was determined not to stop the treatment. I did feel some pain during the sonications, but it was temporary.” Following her treatment, Anya’s only noticeable side effects were some facial swelling and grogginess, but both resolved after a few days. More importantly, she experienced a significant reduction in her OCD symptoms. “After the treatment, my OCD symptoms gradually started to improve. I think the turning point was in March, a couple of months after the procedure, when we received an invitation to a relative’s wedding in Los Angeles. To my parents’ surprise and delight, I said that I wanted to go. Before the treatment, it would have been completely unthinkable for me to want to travel to attend a social event, let alone one with a lot of music. In time, I also noticed that interventions that didn’t help before – like medications and cognitive behavioral therapy – were now a lot more helpful. My OCD has improved tremendously.” Now, five years later, Anya does not consider herself cured from the disease, but she says it’s in remission. “Every now and again, if I’m exhausted or stressed, I do get some flare-ups of earworms or intrusive thoughts, but it’s not nearly as debilitating as it was, and it passes a lot faster. The symptoms now are a lot more manageable and are not getting in the way of my life anymore the way they were before the focused ultrasound.” Since focused ultrasound, Anya has been able to return to work, attend school, and travel. “I have worked as a teacher for a few years, including throughout the pandemic, teaching French, English as a Second Language, and social science subjects. I also went back to school to complete a master’s degree and traveled to Budapest for an internship as part of the program. On that trip, I visited Zagreb, Vienna, and Prague.” She reports she has noticed a change in her relationships with family and friends and is looking forward to a major milestone this fall. “I have made new friends, and I met my now fiancé in 2020. We’re getting married in October. But most importantly, my recovery has made my parents and extended family so happy. It is a miracle, ...
The Foundation recently worked with Bloomberg Businessweek reporter Noah Buhayar on the article, “Surgeons Cut a Giant Tumor Out of my Head. Is There a Better Way?,” where he recounts learning of focused ultrasound and the Foundation during his personal journey with a benign brain tumor. Though not a candidate for focused ultrasound, Buhayar shares how close friend and Foundation supporter Ted Weschler introduced him to the technology and the “potential for a post-scalpel future in which high-frequency sound waves augment and advance treatments for more than 170 medical afflictions.” Weschler has called focused ultrasound “the best investment he’s ever made.” The article includes Buhayar’s first-hand account observing an essential tremor patient being treated with focused ultrasound at the University of Virginia. He goes onto share exciting research exploring the technology’s role in sonodynamic therapy, immunotherapy, and blood-brain barrier opening. Highlights are also included from interviews with Board member and best-selling author John Grisham, former FDA commissioner and Foundation Council member Dr. Andrew von Eschenbach, focused ultrasound pioneer Dr. Kullervo Hynynen, and many others in the field.Buhayar does a masterful job explaining the history and state of focused ultrasound, as well as the Foundation’s urgency in advancing the technology in the shortest time possible. We sincerely hope you’ll read and share this article widely.Click here to access the article without a Bloomberg account for a limited time.
Bloomberg reporter Noah Buhayer shares his experience on being diagnosed with a benign brain tumor, and how focused ultrasound holds the promise for noninvasive brain surgery.
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.